Literature DB >> 11815562

New antimicrobials in the management of cystic fibrosis.

Niels Høiby1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11815562     DOI： 10.1093/jac/49.2.235

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  12 in total

1.  Antibiotic susceptabilities of Pseudomonas aeruginosa isolates derived from patients with cystic fibrosis under aerobic, anaerobic, and biofilm conditions.

Authors:  Dominic Hill; Barbara Rose; Aniko Pajkos; Michael Robinson; Peter Bye; Scott Bell; Mark Elkins; Barbara Thompson; Colin Macleod; Shawn D Aaron; Colin Harbour
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

2.  Single and combination antibiotic susceptibilities of planktonic, adherent, and biofilm-grown Pseudomonas aeruginosa isolates cultured from sputa of adults with cystic fibrosis.

Authors:  Shawn D Aaron; Wendy Ferris; Karam Ramotar; Katherine Vandemheen; Francis Chan; Raphael Saginur
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

3.  Quorum-sensing antagonistic activities of azithromycin in Pseudomonas aeruginosa PAO1: a global approach.

Authors:  Yusuf Nalca; Lothar Jänsch; Florian Bredenbruch; Robert Geffers; Jan Buer; Susanne Häussler
Journal:  Antimicrob Agents Chemother       Date:  2006-05       Impact factor: 5.191

4.  Antibiotic tolerance induced by lactoferrin in clinical Pseudomonas aeruginosa isolates from cystic fibrosis patients.

Authors:  María T Andrés; Mónica Viejo-Diaz; Francisco Pérez; José F Fierro
Journal:  Antimicrob Agents Chemother       Date:  2005-04       Impact factor: 5.191

5.  Enhanced immunogenicity in the murine airway mucosa with an attenuated Salmonella live vaccine expressing OprF-OprI from Pseudomonas aeruginosa.

Authors:  Heinz Arnold; Dirk Bumann; Melanie Felies; Britta Gewecke; Meike Sörensen; J Engelbert Gessner; Joachim Freihorst; Bernd Ulrich von Specht; Ulrich Baumann
Journal:  Infect Immun       Date:  2004-11       Impact factor: 3.441

6.  Preliminary results of a novel quorum sensing inhibitor against pneumococcal infection and biofilm formation with special interest to otitis media and cochlear implantation.

Authors:  Raşit Cevizci; Mehmet Düzlü; Yasemin Dündar; Ningur Noyanalpan; Nedim Sultan; Hakan Tutar; Yıldırım A Bayazıt
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-02-26       Impact factor: 2.503

Review 7.  Efflux-mediated drug resistance in bacteria.

Authors:  Xian-Zhi Li; Hiroshi Nikaido
Journal:  Drugs       Date:  2004       Impact factor: 9.546

8.  Antibiotic resistance in Pseudomonas aeruginosa strains with increased mutation frequency due to inactivation of the DNA oxidative repair system.

Authors:  L F Mandsberg; O Ciofu; N Kirkby; L E Christiansen; H E Poulsen; N Høiby
Journal:  Antimicrob Agents Chemother       Date:  2009-03-30       Impact factor: 5.191

9.  Pseudomonas aeruginosa biofilms exposed to imipenem exhibit changes in global gene expression and beta-lactamase and alginate production.

Authors:  Niels Bagge; Martin Schuster; Morten Hentzer; Oana Ciofu; Michael Givskov; Everett Peter Greenberg; Niels Høiby
Journal:  Antimicrob Agents Chemother       Date:  2004-04       Impact factor: 5.191

10.  Dynamics and spatial distribution of beta-lactamase expression in Pseudomonas aeruginosa biofilms.

Authors:  Niels Bagge; Morten Hentzer; Jens Bo Andersen; Oana Ciofu; Michael Givskov; Niels Høiby
Journal:  Antimicrob Agents Chemother       Date:  2004-04       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.